Galmed Pharmaceuticals Ltd.
Hedge Funds Holdings
Last updated:
Galmed Pharmaceuticals Ltd.‘s stocks are currently a part of 21 hedge funds’ portfolios, which represents 11.42% of the total amount of its stocks outstanding. This makes up a total of 2.80M shares of Galmed Pharmaceuticals Ltd.. Compared to the previous quarter, the number fell by -27.46% or -1.06M shares fewer. As for the holding position changes, 9.52% (2) of current hedge fund investors increased the number of shares held, 19.05% (4) of current holders sold a part of the shares held, and 23.81% (5) closed the holdings completely. 4 hedge funds are new holders of Galmed Pharmaceuticals Ltd. stock in Q1 2022, it is 19.05% of total holders.
Hedge funds holding Galmed Pharmaceuticals Ltd. (Q2 2017 – Q1 2022)
| Q2 2017 | 10 |
|---|---|
| Q3 2017 | 11 |
| Q4 2017 | 19 |
| Q1 2018 | 19 |
| Q2 2018 | 44 |
| Q3 2018 | 37 |
| Q4 2018 | 41 |
| Q1 2019 | 33 |
| Q2 2019 | 32 |
| Q3 2019 | 29 |
| Q4 2019 | 30 |
| Q1 2020 | 30 |
| Q2 2020 | 25 |
| Q3 2020 | 23 |
| Q4 2020 | 21 |
| Q1 2021 | 29 |
| Q2 2021 | 24 |
| Q3 2021 | 24 |
| Q4 2021 | 22 |
| Q1 2022 | 21 |
Hedge funds changes in Galmed Pharmaceuticals Ltd. positions (Q2 2017 – Q1 2022)
| Q2 2017 | 4 | 1 | 0 | 1 | 4 |
|---|---|---|---|---|---|
| Q3 2017 | 3 | 4 | 1 | 2 | 1 |
| Q4 2017 | 12 | 4 | 0 | 4 | -1 |
| Q1 2018 | 3 | 8 | 4 | 3 | 1 |
| Q2 2018 | 32 | 5 | 3 | 7 | -3 |
| Q3 2018 | 11 | 9 | 7 | 18 | -8 |
| Q4 2018 | 12 | 9 | 12 | 7 | 1 |
| Q1 2019 | 5 | 8 | 10 | 13 | -3 |
| Q2 2019 | 3 | 12 | 9 | 4 | 4 |
| Q3 2019 | 4 | 7 | 7 | 6 | 5 |
| Q4 2019 | 7 | 8 | 6 | 5 | 4 |
| Q1 2020 | 4 | 10 | 6 | 4 | 6 |
| Q2 2020 | 3 | 8 | 3 | 8 | 3 |
| Q3 2020 | 3 | 6 | 5 | 5 | 4 |
| Q4 2020 | 4 | 6 | 5 | 7 | -1 |
| Q1 2021 | 9 | 5 | 4 | 1 | 10 |
| Q2 2021 | 3 | 3 | 9 | 8 | 1 |
| Q3 2021 | 3 | 6 | 5 | 3 | 7 |
| Q4 2021 | 5 | 3 | 5 | 8 | 1 |
| Q1 2022 | 4 | 2 | 4 | 5 | 6 |
Hedge funds changes in Galmed Pharmaceuticals Ltd. stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 0 | 0 |
|---|---|---|
| Q3 2017 | 0 | 0 |
| Q4 2017 | 0 | 0 |
| Q1 2018 | 0 | 0 |
| Q2 2018 | 0 | 0 |
| Q3 2018 | 0 | 172,000 |
| Q4 2018 | 87,000 | 126,000 |
| Q1 2019 | 0 | 111,000 |
| Q2 2019 | 0 | 74,000 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 3,000 | 0 |
| Q1 2020 | 1,000 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 51,000 | 0 |
| Q2 2021 | 81,000 | 194,000 |
| Q3 2021 | 80,000 | 504,000 |
| Q4 2021 | 51,000 | 429,000 |
| Q1 2022 | 31,000 | 16,000 |